Publicacións nas que colabora con José Juan García Marín (9)

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

2016

  1. Protective role of biliverdin against bile acid-induced oxidative stress in liver cells

    Free Radical Biology and Medicine, Vol. 97, pp. 466-477

2014

  1. Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2

    European Journal of Nutrition, Vol. 53, Núm. 2, pp. 401-412

  2. The effect of acetaminophen on the expression of BCRP in trophoblast cells impairs the placental barrier to bile acids during maternal cholestasis

    Toxicology and Applied Pharmacology, Vol. 277, Núm. 1, pp. 77-85

  3. The expression of genes involved in hepatocellular carcinoma chemoresistance is affected by mitochondrial genome depletion

    Molecular Pharmaceutics, Vol. 11, Núm. 6, pp. 1856-1868

2013

  1. Mitochondrial genome depletion in human liver cells abolishes bile acid-induced apoptosis: Role of the Akt/mTOR survival pathway and Bcl-2 family proteins

    Free Radical Biology and Medicine, Vol. 61, pp. 218-228

2012

  1. Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins

    Molecular Pharmaceutics, Vol. 9, Núm. 9, pp. 2565-2576

2011

  1. A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis

    Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 219-225

  2. Mitochondrial genome depletion dysregulates bile acid- and paracetamol-induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells

    British Journal of Pharmacology, Vol. 162, Núm. 8, pp. 1686-1699